238 related articles for article (PubMed ID: 33578746)
21. A multi-sequence and habitat-based MRI radiomics signature for preoperative prediction of MGMT promoter methylation in astrocytomas with prognostic implication.
Wei J; Yang G; Hao X; Gu D; Tan Y; Wang X; Dong D; Zhang S; Wang L; Zhang H; Tian J
Eur Radiol; 2019 Feb; 29(2):877-888. PubMed ID: 30039219
[TBL] [Abstract][Full Text] [Related]
22. Pre-operative MRI radiomics model non-invasively predicts key genomic markers and survival in glioblastoma patients.
Pease M; Gersey ZC; Ak M; Elakkad A; Kotrotsou A; Zenkin S; Elshafeey N; Mamindla P; Kumar VA; Kumar AJ; Colen RR; Zinn PO
J Neurooncol; 2022 Oct; 160(1):253-263. PubMed ID: 36239836
[TBL] [Abstract][Full Text] [Related]
23. Fusion Radiomics Features from Conventional MRI Predict MGMT Promoter Methylation Status in Lower Grade Gliomas.
Jiang C; Kong Z; Liu S; Feng S; Zhang Y; Zhu R; Chen W; Wang Y; Lyu Y; You H; Zhao D; Wang R; Wang Y; Ma W; Feng F
Eur J Radiol; 2019 Dec; 121():108714. PubMed ID: 31704598
[TBL] [Abstract][Full Text] [Related]
24. Negative prognostic impact of epidermal growth factor receptor copy number gain in young adults with isocitrate dehydrogenase wild-type glioblastoma.
Hoffman DI; Abdullah KG; McCoskey M; Binder ZA; O'Rourke DM; Desai AS; Nasrallah MP; Bigdeli A; Morrissette JJD; Brem S; Bagley SJ
J Neurooncol; 2019 Nov; 145(2):321-328. PubMed ID: 31542863
[TBL] [Abstract][Full Text] [Related]
25. Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma.
Cheng W; Li M; Jiang Y; Zhang C; Cai J; Wang K; Wu A
J Neurosurg; 2016 Jul; 125(1):7-16. PubMed ID: 26544773
[TBL] [Abstract][Full Text] [Related]
26. Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients.
Gao WZ; Guo LM; Xu TQ; Yin YH; Jia F
J Transl Med; 2018 Dec; 16(1):368. PubMed ID: 30572911
[TBL] [Abstract][Full Text] [Related]
27. Preoperative Magnetic Resonance Imaging Radiomics for Predicting Early Recurrence of Glioblastoma.
Wang J; Yi X; Fu Y; Pang P; Deng H; Tang H; Han Z; Li H; Nie J; Gong G; Hu Z; Tan Z; Chen BT
Front Oncol; 2021; 11():769188. PubMed ID: 34778086
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of MGMT promoter methylation in glioblastoma patients treated with temozolomide-based chemoradiation: a Portuguese multicentre study.
Costa BM; Caeiro C; Guimarães I; Martinho O; Jaraquemada T; Augusto I; Castro L; Osório L; Linhares P; Honavar M; Resende M; Braga F; Silva A; Pardal F; Amorim J; Nabiço R; Almeida R; Alegria C; Pires M; Pinheiro C; Carvalho E; Lopes JM; Costa P; Damasceno M; Reis RM
Oncol Rep; 2010 Jun; 23(6):1655-62. PubMed ID: 20428822
[TBL] [Abstract][Full Text] [Related]
29. Ten Years of VASARI Glioma Features: Systematic Review and Meta-Analysis of Their Impact and Performance.
Azizova A; Prysiazhniuk Y; Wamelink IJHG; Petr J; Barkhof F; Keil VC
AJNR Am J Neuroradiol; 2024 Jun; ():. PubMed ID: 38937115
[TBL] [Abstract][Full Text] [Related]
30. Radiomic MRI Phenotyping of Glioblastoma: Improving Survival Prediction.
Bae S; Choi YS; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Lee SK
Radiology; 2018 Dec; 289(3):797-806. PubMed ID: 30277442
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of O6-methylguanine-DNA-methyltransferase (MGMT) promoter methylation and isocitrate dehydrogenase-1 (IDH-1) mutation in glioblastoma multiforme patients: A single-center experience in the Middle East region.
Ayoub Z; Geara F; Najjar M; Comair Y; Khoueiry-Zgheib N; Khoueiry P; Mahfouz R; Boulos FI; Kamar FG; Andraos T; Saadeh F; Kreidieh F; Abboud M; Skaf G; Assi HI
Clin Neurol Neurosurg; 2019 Jul; 182():92-97. PubMed ID: 31108342
[TBL] [Abstract][Full Text] [Related]
32. XGBoost Improves Classification of MGMT Promoter Methylation Status in IDH1 Wildtype Glioblastoma.
Le NQK; Do DT; Chiu FY; Yapp EKY; Yeh HY; Chen CY
J Pers Med; 2020 Sep; 10(3):. PubMed ID: 32942564
[TBL] [Abstract][Full Text] [Related]
33. A Deep Learning-Based Radiomics Model for Prediction of Survival in Glioblastoma Multiforme.
Lao J; Chen Y; Li ZC; Li Q; Zhang J; Liu J; Zhai G
Sci Rep; 2017 Sep; 7(1):10353. PubMed ID: 28871110
[TBL] [Abstract][Full Text] [Related]
34. The TERT promoter mutation status and MGMT promoter methylation status, combined with dichotomized MRI-derived and clinical features, predict adult primary glioblastoma survival.
Shu C; Wang Q; Yan X; Wang J
Cancer Med; 2018 Aug; 7(8):3704-3712. PubMed ID: 29984907
[TBL] [Abstract][Full Text] [Related]
35. Radiomic Analysis to Predict Outcome in Recurrent Glioblastoma Based on Multi-Center MR Imaging From the Prospective DIRECTOR Trial.
Vils A; Bogowicz M; Tanadini-Lang S; Vuong D; Saltybaeva N; Kraft J; Wirsching HG; Gramatzki D; Wick W; Rushing E; Reifenberger G; Guckenberger M; Weller M; Andratschke N
Front Oncol; 2021; 11():636672. PubMed ID: 33937035
[TBL] [Abstract][Full Text] [Related]
36. IDH mutation and MGMT promoter methylation are associated with the pseudoprogression and improved prognosis of glioblastoma multiforme patients who have undergone concurrent and adjuvant temozolomide-based chemoradiotherapy.
Li H; Li J; Cheng G; Zhang J; Li X
Clin Neurol Neurosurg; 2016 Dec; 151():31-36. PubMed ID: 27764705
[TBL] [Abstract][Full Text] [Related]
37. Isocitrate Dehydrogenase Mutations are Better Prognostic Marker than O6-methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastomas - a Retrospective, Single-centre Molecular Genetics Study of Gliomas.
Houdova Megova M; Drábek J; Dwight Z; Trojanec R; Koudeláková V; Vrbková J; Kalita O; Mlcochova S; Rabcanova M; Hajdúch M
Klin Onkol; 2017; 30(5):361-371. PubMed ID: 29031038
[TBL] [Abstract][Full Text] [Related]
38. AI and High-Grade Glioma for Diagnosis and Outcome Prediction: Do All Machine Learning Models Perform Equally Well?
Pasquini L; Napolitano A; Lucignani M; Tagliente E; Dellepiane F; Rossi-Espagnet MC; Ritrovato M; Vidiri A; Villani V; Ranazzi G; Stoppacciaro A; Romano A; Di Napoli A; Bozzao A
Front Oncol; 2021; 11():601425. PubMed ID: 34888226
[TBL] [Abstract][Full Text] [Related]
39. Predicting survival in patients with glioblastoma using MRI radiomic features extracted from radiation planning volumes.
Geraghty BJ; Dasgupta A; Sandhu M; Malik N; Maralani PJ; Detsky J; Tseng CL; Soliman H; Myrehaug S; Husain Z; Perry J; Lau A; Sahgal A; Czarnota GJ
J Neurooncol; 2022 Feb; 156(3):579-588. PubMed ID: 34981301
[TBL] [Abstract][Full Text] [Related]
40. [Prognostic implication of alterations in epidermal growth factor receptor and MGMT in glioblastoma].
Zhang LY; Ge HJ; Wang LM; Zhao LH; Liu L; Zhang DJ; Cai YN; Lu DH; Piao YS
Zhonghua Bing Li Xue Za Zhi; 2019 Mar; 48(3):186-191. PubMed ID: 30831643
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
